Gene Therapy (Part I)

Author(s): Xi-Biao Jia, Zhi-Yao He

Journal Name: Current Gene Therapy

Volume 20 , Issue 1 , 2020


Become EABM
Become Reviewer
Call for Editor

[1]
Ma CC, Wang ZL, Xu T, et al. The approved gene therapy drugs worldwide: from 1998 to 2019. Biotechnol Adv 2020; 40: 107502
[2]
Chen S, Liu Z, Li M, et al. Potential prognostic predictors and molecular targets for skin melanoma screened by weighted gene co-expression network analysis. Curr Gene Ther 2020; 20(1): 5-14.
[3]
Mo F, Luo Y, Fan D, et al. Integrated analysis of mRNA-seq and miRNA-seq to identify c-MYC, YAP1 and miR-3960 as major players in the anticancer effects of caffeic acid phenethyl ester in human small cell lung cancer cell line. Curr Gene Ther 2020; 20(1): 15-24.
[4]
Morishita R, Shimamura M, Takeya Y, et al. Combined analysis of clinical data on HGF gene therapy to treat critical limb ischemia in Japan. Curr Gene Ther 2020; 20(1): 25-35.


free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 1
Year: 2020
Published on: 04 June, 2020
Page: [4 - 4]
Pages: 1
DOI: 10.2174/156652322001200604150311

Article Metrics

PDF: 27
HTML: 4